Sunil Verma

17.9k citations
165 papers · 10.8k · 5 hit papers · h-index 39

Impact in

Papers in

    • HER2/EGFR in Cancer Research 48
    • Cancer Treatment and Pharmacology 39
    • Cancer Immunotherapy and Biomarkers 8
    • Advanced Breast Cancer Therapies 47
    • Lung Cancer Treatments and Mutations 13

Sunil Verma

159 papers receiving 10.6k citations

Sunil Verma's Hit Papers

Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer 2018 · 813 citations
8130+4+9Years since publication50010001.5k2.0k2.5k

Peers

Sunil Verma
Comparison fields: 5 of 133
  • Oncology 6.0k
  • Pulmonary and Respiratory Medicine 4.4k
  • Cancer Research 1.7k
  • Genetics 760
  • Radiology, Nuclear Medicine and Imaging 1.6k
Replace Andrew D. Seidman with:
Andrew D. Seidman United States
Maura N. Dickler United States
Kimberly Blackwell United States
Francesco Cognetti Italy
Sara A. Hurvitz United States
Joyce O’Shaughnessy United States
Young‐Hyuck Im South Korea
Erika Hamilton United States
Carey K. Anders United States
Keyue Ding Canada
Sunil Verma relative to Andrew D. Seidman United States Andrew D. Seidman's profile →
Citations per field
00.5×3.6×
Andrew D. Seidman · 1×
Citations per year

Countries citing papers authored by Sunil Verma

Since Specialization
Citations

This map shows the geographic impact of Sunil Verma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunil Verma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunil Verma more than expected).

Fields of papers citing papers by Sunil Verma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunil Verma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunil Verma. The network helps show where Sunil Verma may publish in the future.

Co-authors

The 25 scholars most cited alongside Sunil Verma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sunil Verma Line = papers co-authored together Sunil Verma links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Hit paper breakdown →
20122724
2
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
Hit paper breakdown →
20161278
3
Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
Hit paper breakdown →
20151140
4
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
Hit paper breakdown →
2018813
5
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
Hit paper breakdown →
2017477
6 2009212
7 2016183
8 2013177
9 2016163
10 2016155
11 2012142
12 2016126
13 2018111
14 2018106
15 2006105
16 201799
17 200696
18 201093
19 201288
20 200787

About Sunil Verma

Sunil Verma is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 165 papers that have together received 10.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (48 papers), Advanced Breast Cancer Therapies (47 papers), Cancer Treatment and Pharmacology (39 papers), Breast Cancer Treatment Studies (33 papers), Lung Cancer Treatments and Mutations (13 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Estrogen and related hormone effects (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Oncology (6.0k citations), Pulmonary and Respiratory Medicine (4.4k citations), Cancer Research (1.7k citations), Genetics (760 citations) and Radiology, Nuclear Medicine and Imaging (1.6k citations). Sunil Verma has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Ian E. Krop, Mark D. Pegram, Véronique Dièras, David Miles, Luca Gianni, Manfred Welslau, Jungsil Ro, Nadia Harbeck, Kim T. Blackwell and Nicholas C. Turner. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, The Oncologist and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact